Theravance Biopharma shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Theravance Biopharma by Hanson McClain Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.0k | 178 | 11.24 |
2023-09-30 | $112 | 13 | 8.69 |
2023-06-30 | $1.1k | 106 | 10.36 |
2023-03-31 | $1.2k | 106 | 10.86 |
2022-03-31 | $11k | 1.1k | 9.73 |
2021-12-31 | $12k | 1.1k | 10.62 |